Zdrowie i gospodarka · 19/11/2008

FDA to Remove Essential-Use Designation for Epinephrine in Oral Pressurized Metered-Dose Inhalers

The US Food and Drug Administration (FDA) is amending its regulation on the use of ozone-depleting substances (ODSs) in self-pressurized containers to remove the essential-use designation for epinephrine used in oral pressurized metered-dose inhalers (MDIs), effective December 31, 2011.